| 标题 |
Comparative clinical and economic outcomes of triple metronomic chemotherapy plus low-dose nivolumab versus conventional induction chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma: results from a phase IV real-world superiority trial |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)